Review
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jun 7, 2006; 12(21): 3306-3313
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3306
Antibiotics and probiotics in treatment of inflammatory bowel disease
Paolo Gionchetti, Fernando Rizzello, Karen M Lammers, Claudia Morselli, Lucia Sollazzi, Samuel Davies, Rosy Tambasco, Carlo Calabrese, Massimo Campieri
Paolo Gionchetti, Fernando Rizzello, Karen M Lammers, Claudia Morselli, Lucia Sollazzi, Samuel Davies, Rosy Tambasco, Carlo Calabrese, Massimo Campieri, Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Correspondence to: Paolo Gionchetti, Department of Internal Medicine and Gastroenterology, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. paolo@med.unibo.it
Telephone: +39-51-6364122 Fax: +39-51-392538
Received: July 26, 2005
Revised: July 28, 2005
Accepted: August 25, 2005
Published online: June 7, 2006
Abstract

Many experimental and clinical observations suggest that intestinal microflora plays a potential role in the pathogenesis of inflammatory bowel disease (IBD). Manipulation of the luminal content using antibiotics or probiotics represents a potentially effective therapeutic option. The available studies do not support the use of antibiotics in ulcerative colitis (UC). Antibiotics are effective in treating septic complications of Crohn’s disease (CD) but their use as a primary therapy is more controversial, although this approach is frequently and successfully adopted in clinical practice.

There is evidence that probiotic therapy may be effective in the prevention and treatment of mild to moderate UC. In contrast, a lack of successful study data at present precludes the widespread use of probiotics in the treatment of CD.

Both antibiotics and probiotics appear to play a beneficial role in the treatment and prevention of pouchitis and further trials are warranted to fully quantify their clinical efficacy.

Keywords: Inflammatory bowel disease; Intestinal microflora; Antibiotics; Probiotics